1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Primary efficacy end point at a median of 6 months (range, 1–38 months)a
Aneurysm Location Aneurysm Occlusion Occlusion Rateb (%) Total <50 50–95 >95 100 Anterior circulation (ICA) 6 (6.1%) 11 (11.2%) 4 (4.1%) 77 (78.6%) 98 Petrocavernous 1 3 4 Cavernous 2 2 12 16 Carotid cave 1 3 4 Superior hypophyseal 1 3 4 Paraophthalmic 2 2 24 28 Paraclinoid 3 3 Supraclinoid 1 1 3 5 Posterior communicating artery 1 4 2 24 31 Anterior choroidal artery 1 2 3 Anterior circulation distal to circle of Willis 2 (5.3%) 9 (23.7%) 2 (5.3%) 25 (65.8%) 38 ICA terminus 1 1 1 2 5 Anterior cerebral artery (including AcomA) 1 1 7 9 Middle cerebral artery 1 7 16 24 Posterior circulation 1 (4.5%) 2 (9.1%) 3 (13.6%) 16 (72.7%) 22 VA and VB junction 1 7 8 Posterior inferior cerebellar artery 1 2 2 5 Basilar trunk 1 1 4 6 Posterior cerebral artery 3 3 Total 9 (6%) 22 (13%) 9 (6%) 118 (75%) 158
Note:—AcomA indicates anterior communicating artery; VA, vertebral artery; VB, vertebrobasilar.
↵a Digital subtraction angiography follow-up was available in 158 aneurysms (86.8%).
↵b Occlusion rates at the latest follow-up are based on aneurysm volume calculated on pre-and posttreatment digital subtraction angiograms.